AGP Picks
View all

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on October 13, 2026

KT Medical Staffing Highlights Senior Living Placement as a Family Advisory Service in Orange County
Early Signal Diagnostics sends it’s scientific advisory board to Boston Conference
Elizabeth M. Lykins, Author, Says Spiritual Awakening Begins Within, Not Through Dangerous Psychedelics
Sarah Oelschig, Author and Advocate, Champions the Art of Subtraction to Help Adults Overcome Burnout
New Prop 38 Ad Shares a California Caregiver’s Alzheimer’s Story and her Case for Cures in our Lifetime
ALZHEIMER’S FAMILY CENTER PIONEER IN ALZHEIMER’S & DEMENTIA DAY CARE PRESENTS ERIC RIGLER MOST RECORDED PIPER IN HISTORY
Readily Raises $11 Million Series A to Expand AI Compliance Intelligence and Advance Enterprise Oversight for Healthcare
CureMatch Study in npj Genomic Medicine Validates Digital Reasoning System to Navigate Cancer Complexity
Renaissance Healthcare for Women Shares Menopause Care Perspectives Ahead of World Menopause Day
ForensisGroup Examines the Role of Human Judgment in  AI-Assisted Expert Witness Searches
 Octopyd Launches Talent Review Arena for Evaluating Candidates
Nutraland USA's AKK001™ Receives 2026 NIE New Ingredient Award
Simple Steps Fertility Partners With American Cancer Society to Offer Free Fertility Consults at LA Breast Cancer Walks
Palliative Nurse Lorri C. Jackson Recently Featured on Close Up Radio
SCAN Health Plan and CareMore Health Build on Decades of Serving Medicare Patients with New Medicare Advantage Plan in Southern California
OptraSCAN to Unveil the FDA-Cleared OS-Ultra Scanner at Pathology Visions 2026
Personalized Stem Cells Receives FDA Approval for Novel Stem Cell Treatment Clinical Trial for Traumatic Brain Injury
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153, a CD123-GSPT1 Degrader-Antibody Conjugate
Boster Bio Expands KO/KD-Validated Antibody Portfolio to Strengthen Specificity Evidence

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.